Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata is a chronic condition causing hair loss, with new treatments targeting the immune system showing promise.

Patients with cutaneous lupus erythematosus have a severely impaired quality of life, especially emotionally.

There is no cure for alopecia areata, but treatments like JAK inhibitors show promise.

Methotrexate is a promising and safe treatment for severe alopecia areata, with better results when combined with corticosteroids.

Dutasteride treatment in men with mild to moderate COVID-19 reduced viral shedding, inflammation, and recovery time without serious side effects.

The document concludes that Hidradenitis suppurativa is often underdiagnosed, lacks definitive treatment, and requires better awareness and management strategies.

Tofacitinib helps regrow hair in severe alopecia patients, but more research is needed.

About 11% of patients with secondary syphilis had Syphilitic Alopecia, which usually improved with treatment.

Topical tofacitinib cream may help treat certain hair loss conditions with fewer risks.

New tools and criteria have been developed to better assess and treat pediatric lupus.

Topical tofacitinib is effective and safe for treating alopecia areata.

Early detection and treatment of hair-thread tourniquet syndrome in young girls is important to prevent serious harm.

People with Alopecia areata often have lower Vitamin D levels, which might affect the severity of their condition.

Monocytes might be linked to hair loss after COVID-19.

The conclusion is that Erosive Pustular Dermatosis of the Scalp is a rare condition best treated with strong topical steroids and sometimes systemic treatment.

Androgenetic alopecia significantly affects quality of life, especially for women, who are more willing to pay for treatment.

The study concludes that Traction Alopecia is often overlooked in women and children of color, and better recognition and follow-up care are needed.

Early onset, severe types, nail changes, family history, and body hair loss worsen alopecia areata prognosis; sticking to treatment helps.

Experts recommend personalized treatment plans for best outcomes in managing Alopecia Areata.

308 excimer phototherapy is a safe and effective way to treat hair loss from Alopecia Areata.

Androgenetic alopecia in Nepalese men often starts around age 29, with a possible link to COVID-19 worsening the condition.

Minoxidil shampoo showed slight hair growth but needs longer testing for clear results.

Swiss experts recommend specific guidelines for diagnosing and treating hidradenitis suppurativa to improve patient care.

Insulin resistance might not be enough to worsen blood vessel function in young, nonobese women with polycystic ovary syndrome.

Serum granulysin levels can indicate the activity and prognosis of alopecia areata.

PRP works faster and is a safe alternative to steroids for treating alopecia areata.

Growth factors greatly affect hair loss, with different levels seen in men, women, younger patients, and at the start of the condition.

Baricitinib, a drug for rheumatoid arthritis, atopic dermatitis, and alopecia areata, is generally safe with low risk of major side effects, even in patients with risk factors. It's also effective in promoting hair regrowth in alopecia areata patients.

People with alopecia areata are more likely to have anxiety and depression and a lower quality of life.

The three adipokines—leptin, adiponectin, and resistin—are present in various cells of normal dog skin.